Table 3 Chemotherapy use according to risk of recurrence and fitness.
(a) Use of chemotherapy by risk status. | |||
|---|---|---|---|
Risk | Chemotherapy | No Chemotherapy | Total |
High risk | 376 (24.7%) | 1144 (75.3%) | 1520 (100.0%) |
Non-high risk | 21 (1.6%) | 1270 (98.4%) | 1291 (100.0%) |
Total | 397 (14.1%) | 2414 (85.9%) | 2811 (100.0%) |
(b) Use of chemotherapy by fitness. | |||
|---|---|---|---|
Fitness | Chemotherapy | No Chemotherapy | Total |
Fit | 322 (15.6%) | 1737 (84.4%) | 2059 (100.0%) |
Vulnerable | 75 (10.0%) | 675 (90.0%) | 750 (100.0%) |
Frail | 0 (0.0%) | 2 (100.0%) | 2 (100.0%) |
Total | 397 (14.1%) | 2414 (85.9%) | 2811 (100.0%) |
(c) Use of chemotherapy by risk and fitness. | |||||
|---|---|---|---|---|---|
Fitness | High risk | Non-high risk | Total | ||
Chemotherapy | No chemotherapy | Chemotherapy | No chemotherapy | ||
Fit | 306 (14.9%) | 794 (38.6%) | 16 (0.8%) | 943 (45.8%) | 2059 (100.0%) |
Vulnerable | 70 (9.3%) | 349 (46.5%) | 5 (0.7%) | 326 (43.5%) | 750 (100.0%) |
Frail | 0 (0.0%) | 1 (50%) | 0 (0.0%) | 1 (50%) | 2 (100%) |
Total | 376 (13.4%) | 1144 (40.7%) | 21 (0.7%) | 1270 (45.2%) | 2811 (100.0%) |
